FDAnews
www.fdanews.com/articles/202328-siemens-healthineers-earns-ce-mark-for-cardiac-troponin-point-of-care-test
CE mark

Siemens Healthineers Earns CE Mark for Cardiac Troponin Point-of-Care Test

April 14, 2021

Siemens Healthineers has obtained CE mark certification for its Atellica VTLi Patient-Side Immunoassay Analyzer, a device that offers a point-of-care test that can aid in diagnosing heart attacks.

The eight-minute fingerstick test helps clinicians to quickly diagnose heart attacks by measuring levels of cardiac troponin, a group of proteins found in the heart muscles that are released following damage.

The company said that its analyzer offers the first high-sensitivity troponin I test that requires only a fingerstick-blood sample. The system has wireless capability that allows it to directly connect to data management systems.

View today's stories